share_log

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $3.5 Price Target

Benzinga ·  Nov 13, 2023 10:31

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $3.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment